Company Search:
Advanced Search
Sponsored Links
Spark Therapeutics Inc Company Snapshot
Spark Therapeutics Inc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Spark Therapeutics Inc with three other companies in this sector in the United States: Jounce Therapeutics Inc (2018 sales of $65.20 million of which 100% was Immunotherapy), Cytomx Therapeutics Inc ($59.50 million of which 100% was Pharmaceutical), and Principia Biopharma Inc ($69.14 million of which 100% was Biopharmaceutical).

Sales Analysis.
  Stock Performance Chart for Spark Therapeutics Inc
  Stock Data: Recent Stock Performance:
  Current Price (12/13/2019): 110.75
(Figures in U.S. Dollars)
1 Week 0.1%   13 Weeks -0.1%  
4 Weeks 5.7%   52 Weeks 176.3%  
Spark Therapeutics Inc Key Data:
  Ticker: ONCE Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 64,725,000
(Year Ending Jan 2019).
Employees: N/A
  Currency: U.S. Dollars Market Cap: N/A
  Fiscal Yr Ends: December Shares Outstanding: N/A
  Share Type: Common Closely Held Shares: N/A
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.